Joslin Leadership

Critical to the success of a world-class institution like Joslin is solid leadership. To maintain the Center's level of excellence in diabetes research, care and education, Joslin's Boards of Trustees and Overseers work in tandem with the executive team. Together, executives and volunteers ensure Joslin is grounded on a steady foundation, yet has the freedom to create new knowledge—a hallmark of this one-of-a-kind Center.

Publicly representing the institution, Joslin's Board comprises local, national and international philanthropic leaders who have a special connection to Joslin and a shared goal of conquering diabetes in all of its forms.

Board of Trustees

Overseers

Joslin President and CEO

Officers of the Corporation

Board of Trustees

Martin J. Abrahamson, M.D., Senior Vice President and Joslin Clinic Medical Director, Joslin Diabetes Center, Boston, MA

T. Keith Blackwell, M.D., Ph.D., Senior Investigator and Head of the Section on Developmental and Stem Cell Biology, Joslin Diabetes Center, Boston, MA

John L. Brooks, III, Vice Chairman of the Board, General Partner, Prism Venture Partners, Westwood, MA

C. Richard Carlson, Senior Vice President, UBS Financial Service, Inc., Boston, MA

Don R. Conlan, South Pasadena, CA

Kevin E. Conley, Chairman of the Board, Joslin Diabetes Center; President and CEO, Conley & Company, Boston, MA

John J. Cook, Jr., Managing Director, Seaward Management Corp., Wellesley, MA

Nathaniel S. Gardiner, Edwards Angell Palmer & Dodge, Boston, MA

Phillip Gorden, M.D., NIDDK Director Emeritus, National Institutes of Health, Bethesda, MD

Morella M. Grossmann, Caracas, Venezuela

Dennis C. Guittarr, Duxbury, MA

Charles H. Hood, Brookline, MA

Ralph M. James, Executive Director, Executive Education, Harvard Business School, Boston, MA

C. Ronald Kahn, M.D., Senior Investigator and Head of the Section on Obesity and Hormone Action, the Mary K. Iacocca Professor of Medicine at Harvard Medical School, and Vice Chairman of the Joslin Board, Joslin Diabetes Center, Boston, MA

Ranch C. Kimball, President and CEO, Joslin Diabetes Center, Boston, MA

Steven N. Kane, Brookline, MA

George L. King, M.D., Senior Vice President and Research Director, Joslin Diabetes Center, Boston, MA

Ann M. Lagasse, Piper Properties Management, Newburyport, MA

Gary W. Loveman, Chairman, President and CEO, Harrah's Entertainment Inc., Las Vegas, NV

Peter H. Mattoon, CEO, SCS Financial, LLC, Waltham, MA

W. Alan McCollough, Richmond, VA

Robert E. Patterson, Chairman Emeritus, Joslin Diabetes Center; Chairman, Cabot Properties, Boston, MA.

James L. Peterson, JLP Group, Geneva, Switzerland

Geoffrey S. Rehnert, Founder and Co-CEO, Audax Management Co. LLC, Boston, Mass.

Richard A. Smith, Chestnut Hill, MA

Christopher T. Stix, Weston, MA

J. Christine Wilson, Pittsford, NY; Vice Chairman of the Board, Joslin Diabetes Center, Boston, MA

Howard Wolpert, M.D., Director, Insulin Pump Program, Joslin Diabetes Center, Boston, MA

William T. Young, Jr., President, W.T. Young, Inc., Lexington, KY

Honorary Trustees:

George F. Cahill, Jr., M.D., Stoddard, NH

Herbert G. Graetz, West Newton, MA

Patrick H. O’Neill, New Canaan, CT

Kenneth E. Quickel, M.D., Centerville, MA